OrganOx Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $6.07M
Latest Deal Amount
  • Investors
  • 12

OrganOx General Information

Description

Developer of organ preservation and maintenance devices designed to preserve liver. The company's devices store liver at normal body temperatures for extended periods of time, enabling healthcare providers to prevent the decay of the organ prior to transplantation,

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Surgical Devices
Primary Office
  • Oxford Science Park
  • Sherrington Building, Magdalen Centre, Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865 000000

OrganOx Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OrganOx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 08-Jan-2020 $6.07M 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 31-Jan-2019 000.00 000.00 000.00 Completed Generating Revenue
6. Later Stage VC 19-Oct-2018 00.000 0000 Completed Generating Revenue
5. Later Stage VC (Series F) 10-Jun-2014 00.000 000.00 000.00 Completed Generating Revenue
4. Grant 10-Jun-2013 00.000 Completed Startup
3. Later Stage VC (Series C) 09-May-2012 00.000 00.000 000.00 Completed Startup
2. Early Stage VC (Series B) 07-Feb-2011 $4.38M $6.69M 000.00 Completed Startup
1. Early Stage VC (Series A) 15-Dec-2008 $2.31M $2.31M 00.00 Completed Startup
To view OrganOx’s complete valuation and funding history, request access »

OrganOx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Series F 000,000 00.000000 000.00 000.00 00 000.00 00.00
Series E 500 $0.013125 $17.04 $17.04 1x $17.04 0.04%
Series D 2,500 $0.013125 $15.49 $15.49 1x $15.49 0.22%
To view OrganOx’s complete cap table history, request access »

OrganOx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of organ preservation and maintenance devices designed to preserve liver. The company's devices store liver at
Other Devices and Supplies
Oxford, United Kingdom
20 As of 2017
000.00
00.00 0000-00-00
0000000000 0 000.00

00000000

ute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exc
00000000000 0000000
Hilden, Germany
0 As of 0000
000.00
0000000000 0 000.00

00000000

n voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
00000000 0000000
Andover, MA
000 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OrganOx Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Coramaze Technologies Venture Capital-Backed Hilden, Germany 0 000.00 0000000000 0 000.00
00000000000 Formerly VC-backed Andover, MA 000 00000 00000000 00000
00000000 Private Equity-Backed Gainesville, FL 000 000000000 00
00000000 000000000 Venture Capital-Backed Emeryville, CA 00 000.00 000000000 - 000.00
000 Formerly PE-Backed Leesburg, VA 000 00000 000000&0 00000
You’re viewing 5 of 16 competitors. Get the full list »

OrganOx Executive Team (9)

Name Title Board Seat Contact Info
Craig Marshall Chief Executive Officer & Board Member
Graham Yeatman Chief Financial Officer & Board Member
Andy Self Director, Commercial
Andrew Cook Ph.D Software Developer
Peter Friend Co-Founder, Board Member & Chief Medical Officer
You’re viewing 5 of 9 executive team members. Get the full list »

OrganOx Board Members (10)

Name Representing Role Since
Adam Workman Oxford University Innovation Board Member 000 0000
Constantin Coussios Ph.D Self Co-Founder, Board Member & Chief Technical Officer 000 0000
Craig Marshall OrganOx Chief Executive Officer & Board Member 000 0000
George Robinson Oxford Investment Consultants Board Observer 000 0000
Graham Yeatman OrganOx Chief Financial Officer & Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

OrganOx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OrganOx Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BGF Growth/Expansion Minority 000 0000 000000 0
GT Healthcare Capital Partners Venture Capital Minority 000 0000 000000 0
Boost&Co Lender/Debt Provider Minority 000 0000 000000 0
Oxford Investment Consultants Other Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »